A case of skin necrosis at the sites of injection of subcutaneous heparin is described. The patient went on to develop heparin-induced thrombocytopenia and pulmonary embolism. Review of the previously described cases of heparin-associated skin necrosis reveais that this sequence of events is not uncommon.
Introduction
Low-dose subcutaneous heparin administration to prevent deep venous thrombosis and pulmonary embolism in surgical patients is of proven value. ' Other than an increase in usually minor haemorrhagic problems, this is associated with few side effects. Among the rarer but more serious side effects are skin necrosis at the site of injection of subcutaneous heparin, first reported by O'Toole in 1973,2 and thombocytopenia, which can be profound. 3 Here we report a case in which these two problems coincided. only 16 reported cases4 and since then, to our knowledge, only one more has been added.5 These 17 cases include 7 males and 10 females, ranging in age from 27 to 79 years. In all but one case skin changes occurred after 6 to 14 days, and they have been associated with both bovine and porcine heparins. Eight patients have required debridement of necrotic tissue and three skin grafting. The pathogenesis is uncertain, although the results of histological studies have suggested that it is a hypersensitivity reaction. This may take the form of heparin-induced immune aggregation of platelets, resulting in ischaemia,6 or an Arthus type reaction with the formation of antigen-antibody complexes.7 A further, non-immunological mechanism might be responsible, where there is incorrect intradermal administration of the heparin, with local haemorrhage in a tense dermis leading to pressure on small blood vessels and subsequent ischaemic necrosis of the overlying skin.5 The patient in whom this occurred developed necrosis after 2 months of heparin therapy, and there were no further problems after correction of injection technique.
Heparin-associated thrombocytopenia is relatively common, the quoted incidence varying between I and 5% in more recent prospective studies.3 A mild fall in the platelet count is probably even more common, possibly related to the temporary sequestration of platelets. to suggest a common immunological mechanism.
We conclude that it is important to avoid the use of intravenous heparin in patients who develop heparin-associated skin necrosis, and to be aware that there is an increased risk of thrombocytopenia and thrombotic complications in this situation.
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